Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference [Yahoo! Finance]
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference